Stock Analysis Report

Header cover image

Executive Summary

Amrutanjan Health Care Limited produces and sells ayurvedic pain balms in India. More Details


Earnings grew by 25.3% over the past year

Risk Analysis

No risks detected for 590006 from our risk checks.

Snowflake Analysis

Outstanding track record with flawless balance sheet.

Share Price & News

How has Amrutanjan Health Care's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: 590006 has not had significant price volatility in the past 3 months.

Market Performance

7 Day Return




IN Pharmaceuticals


IN Market

1 Year Return




IN Pharmaceuticals


IN Market

Return vs Industry: 590006 underperformed the Indian Pharmaceuticals industry which returned 42.7% over the past year.

Return vs Market: 590006 underperformed the Indian Market which returned -1.4% over the past year.

Shareholder returns

7 Day-2.6%-2.2%-1.1%
30 Day-5.6%-3.1%2.0%
90 Day-5.2%7.5%6.4%
1 Year-4.3%-4.7%44.5%42.7%0.4%-1.4%
3 Year40.5%38.0%22.7%19.3%-3.9%-8.6%
5 Year78.3%72.3%0.08%-3.5%38.9%28.5%

Price Volatility Vs. Market

How volatile is Amrutanjan Health Care's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is Amrutanjan Health Care undervalued compared to its fair value and its price relative to the market?


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: 590006 (₹408.65) is trading above our estimate of fair value (₹79.49)

Significantly Below Fair Value: 590006 is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: 590006 is poor value based on its PE Ratio (37x) compared to the IN Pharmaceuticals industry average (22.7x).

PE vs Market: 590006 is poor value based on its PE Ratio (37x) compared to the Indian market (16.1x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 590006's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 590006 is overvalued based on its PB Ratio (7.5x) compared to the IN Pharmaceuticals industry average (2.2x).

Next Steps

Future Growth

How is Amrutanjan Health Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amrutanjan Health Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Next Steps

Past Performance

How has Amrutanjan Health Care performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 590006 has high quality earnings.

Growing Profit Margin: 590006's current net profit margins (12.2%) are higher than last year (9.8%).

Past Earnings Growth Analysis

Earnings Trend: 590006's earnings have grown by 12.5% per year over the past 5 years.

Accelerating Growth: 590006's earnings growth over the past year (25.3%) exceeds its 5-year average (12.5% per year).

Earnings vs Industry: 590006 earnings growth over the past year (25.3%) exceeded the Pharmaceuticals industry 14.7%.

Return on Equity

High ROE: 590006's Return on Equity (20.2%) is considered high.

Next Steps

  • Explore strong past performing companies in the Pharmaceuticals & Biotech industry.

Financial Health

How is Amrutanjan Health Care's financial position?

Financial Position Analysis

Short Term Liabilities: 590006's short term assets (₹1.3B) exceed its short term liabilities (₹390.6M).

Long Term Liabilities: 590006's short term assets (₹1.3B) exceed its long term liabilities (₹68.6M).

Debt to Equity History and Analysis

Debt Level: 590006 is debt free.

Reducing Debt: 590006 has no debt compared to 5 years ago when its debt to equity ratio was 2.5%.

Debt Coverage: 590006 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 590006 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Next Steps


What is Amrutanjan Health Care current dividend yield, its reliability and sustainability?


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 590006's dividend (0.27%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.56%).

High Dividend: 590006's dividend (0.27%) is low compared to the top 25% of dividend payers in the Indian market (2.31%).

Stability and Growth of Payments

Stable Dividend: 590006's dividend payments have been volatile in the past 10 years.

Growing Dividend: 590006's dividend payments have fallen over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (10%), 590006's dividend payments are thoroughly covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average board tenure


Sambhu Sivalenka (46 yo)

no data




Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Chairman since February 13, 2012. He has been Director of Amrutan ...

CEO Compensation Analysis

Compensation vs Market: Sambhu's total compensation ($USD171.96K) is below average for companies of similar size in the Indian market ($USD316.35K).

Compensation vs Earnings: Sambhu's compensation has been consistent with company performance over the past year.

Board Members

Sambhu Sivalenka
Chairman & MDno data₹12.76m18.78%
₹ 2.3b
Pasumarthi Sathyanarayana Murthi
Non-Executive Director31.17yrs₹420.00k8.71%
₹ 1.1b
Hanehallibhandimat Shetty
Non-Executive & Independent Director17.25yrs₹680.00kno data
Vembu Swaminathan
Non-Executive Independent Director5.42yrs₹820.00k0.0017%
₹ 206.6k
Sambasivam Vydeeswaran
Non-Executive Independent Director6.08yrs₹540.00kno data
Marie Pereira
Non-Executive & Independent Director8.92yrs₹440.00kno data
Govindan Raghavan
Non-Executive Independent Director5.42yrs₹850.00k0.076%
₹ 9.1m


Average Tenure


Average Age

Experienced Board: 590006's board of directors are considered experienced (8.7 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Amrutanjan Health Care Limited's company bio, employee growth, exchange listings and data sources

Key Information

  • Name: Amrutanjan Health Care Limited
  • Ticker: 590006
  • Exchange: BSE
  • Founded: 1893
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹12.082b
  • Shares outstanding: 29.23m
  • Website:

Number of Employees


  • Amrutanjan Health Care Limited
  • No.103 (Old No.42-45), Luz Church Road
  • Mylapore
  • Chennai
  • Tamil Nadu
  • 600004
  • India


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
590006BSE (Mumbai Stock Exchange)YesEquity SharesININRMay 2005
AMRUTANJANNSEI (National Stock Exchange of India)YesEquity SharesININRMay 2005


Amrutanjan Health Care Limited produces and sells ayurvedic pain balms in India. It operates through OTC products, Beverages, and Others segments. The company offers pain management products, including pai ...

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/29 12:46
End of Day Share Price2020/10/29 00:00
Annual Earnings2020/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.